Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17670 | 524 | 53.0 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VPU | Author keyword | 106 | 71% | 16% | 85 |
2 | BST 2 | Author keyword | 44 | 81% | 5% | 26 |
3 | TETHERIN | Author keyword | 33 | 58% | 7% | 38 |
4 | CD317 | Author keyword | 23 | 86% | 2% | 12 |
5 | BST2 | Author keyword | 19 | 76% | 2% | 13 |
6 | HM124 | Author keyword | 8 | 75% | 1% | 6 |
7 | VIRAL BIOCHEM SECT | Address | 6 | 36% | 3% | 14 |
8 | HIV 1 VPU | Author keyword | 6 | 100% | 1% | 4 |
9 | VIRUS RELEASE | Author keyword | 5 | 38% | 2% | 10 |
10 | DOCKING APPROACH | Author keyword | 4 | 67% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VPU | 106 | 71% | 16% | 85 | Search VPU | Search VPU |
2 | BST 2 | 44 | 81% | 5% | 26 | Search BST+2 | Search BST+2 |
3 | TETHERIN | 33 | 58% | 7% | 38 | Search TETHERIN | Search TETHERIN |
4 | CD317 | 23 | 86% | 2% | 12 | Search CD317 | Search CD317 |
5 | BST2 | 19 | 76% | 2% | 13 | Search BST2 | Search BST2 |
6 | HM124 | 8 | 75% | 1% | 6 | Search HM124 | Search HM124 |
7 | HIV 1 VPU | 6 | 100% | 1% | 4 | Search HIV+1+VPU | Search HIV+1+VPU |
8 | VIRUS RELEASE | 5 | 38% | 2% | 10 | Search VIRUS+RELEASE | Search VIRUS+RELEASE |
9 | DOCKING APPROACH | 4 | 67% | 1% | 4 | Search DOCKING+APPROACH | Search DOCKING+APPROACH |
10 | HIV 1 RELEASE | 3 | 100% | 1% | 3 | Search HIV+1+RELEASE | Search HIV+1+RELEASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HIV 1 VPU | 109 | 80% | 13% | 68 |
2 | BST 2 TETHERIN | 72 | 93% | 5% | 27 |
3 | PARTICLE RELEASE | 70 | 54% | 17% | 91 |
4 | INHIBITS HIV 1 | 58 | 66% | 10% | 54 |
5 | VIRUS TYPE 1 VPU | 56 | 84% | 6% | 31 |
6 | RESTRICTION FACTOR | 55 | 54% | 13% | 70 |
7 | TYPE 1 VPU | 47 | 79% | 6% | 30 |
8 | BST 2 | 42 | 94% | 3% | 15 |
9 | TETHERIN | 39 | 74% | 6% | 29 |
10 | VPU PROTEIN | 39 | 46% | 12% | 64 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Antiviral Activities of Tetherin | 2013 | 22 | 159 | 82% |
Counteraction of the multifunctional restriction factor tetherin | 2014 | 11 | 168 | 70% |
HIV-1 Vpu - an ion channel in search of a job | 2014 | 6 | 110 | 91% |
BST-2/tetherin: Structural biology, viral antagonism, and immunobiology of a potent host antiviral factor | 2013 | 14 | 87 | 76% |
The Great Escape: Viral Strategies to Counter BST-2/Tetherin | 2010 | 59 | 49 | 92% |
BST-2/tetherin: a new component of the innate immune response to enveloped viruses | 2010 | 88 | 67 | 70% |
Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction | 2011 | 26 | 98 | 84% |
Mechanisms underlying HIV-1 Vpu-mediated viral egress | 2014 | 3 | 78 | 77% |
Emerging Role of the Host Restriction Factor Tetherin in Viral Immune Sensing | 2013 | 11 | 75 | 59% |
Modulation of HIV-1-host interaction: role of the Vpu accessory protein | 2010 | 48 | 161 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIRAL BIOCHEM SECT | 6 | 36% | 2.7% | 14 |
2 | BIONANOTECHNOL INTERDISCIPLINARY ABORAT | 3 | 57% | 0.8% | 4 |
3 | ISU ABXIS CO LTD | 2 | 67% | 0.4% | 2 |
4 | UNIDAD EXP VIRAL | 2 | 67% | 0.4% | 2 |
5 | UNIV HOSP MED GENEVA | 2 | 67% | 0.4% | 2 |
6 | HEINRICH PETTE EXPT VIROL | 1 | 50% | 0.4% | 2 |
7 | BIOMEMBRANE STRUCT UNIT | 1 | 11% | 2.1% | 11 |
8 | EPHEUMR754IFR 128 | 1 | 50% | 0.2% | 1 |
9 | MOL VIROL IMMUNOL PASTEUR SHANGHAI | 1 | 50% | 0.2% | 1 |
10 | MRC UCL MOL CELL BIOL | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000290391 | M2 CHANNEL//M2 PROTON CHANNEL//M2 PROTEIN |
2 | 0.0000189596 | NEF//HIV 1 NEF//HIV NEF |
3 | 0.0000175480 | VPR//VPX//HIV 1 VPR |
4 | 0.0000172185 | APOBEC3G//VIF//APOBEC3F |
5 | 0.0000127081 | TRIM5 ALPHA//TRIMCYP//TRIM5 |
6 | 0.0000126345 | VIRUS CELL INTERACT SECT//GAG//M PMV |
7 | 0.0000118309 | IFITM3//IFITM1//IFITM |
8 | 0.0000071658 | SCYTHE//GET PATHWAY//SGTA |
9 | 0.0000068010 | PLASMACYTOID DENDRITIC CELLS//BDCA 4//PLASMACYTOID DENDRITIC CELL |
10 | 0.0000067451 | SIV//SHIV//SIMIAN IMMUNODEFICIENCY VIRUS |